The Use of Cyclosporine in Dermatology

August 2012 | Volume 11 | Issue 8 | Original Article | 979 | Copyright © August 2012


Luis Dehesa MD, Adriana Abuchar MD, Almudena Nuno-Gonzalez MD, Magalys Vitiello MD, and Francisco A. Kerdel BSc MBBS

Florida Academic Dermatology Center, University of Miami Hospital, Miami, FL

  1. Fraser AD, van Kuijk AW, Westhovens R, Karim Z, Wakefield R, Gerards AH, et al. A randomized, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis. Ann Rheum Dis 2005;64:859-64.
  2. Mahrle G, Schulze HJ, Bräutigam M, Mischer P, Schopf R, Jung EG, et al. Anti-inflammatory efficacy of low-dose cyclosporine A in psoriatic arthritis. A prospective multicentre study. Br J Dermatol 1996;135:752-7.
  3. Laburte C, Grossman R, Abi-Rached J et al. Efficacy and safety of oral cyclosporin A (CyA; Sandimmun) for long-term treatment of chronic severe plaque psoriasis. Br J Dermatol 1994; 130:366-375.
  4. Paul CF, et al. Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 year cohort study. J Invest Dermatol. 2003; 120(2):211-16.
  5. Shin Woo, Young Woon, et al. Cyclosporine treatment of Atopic Dermatitis: It is really associated with infectious diseases? Ann Dermatol 2010;22(2): 170-172.
  6. Toyoda M, Morohashi M. Morphological assessment of the effects of cyclosporine A on Mast Cell- Nerve relationship in Atopic Dermatitis. Acta Derm Venereol (Stochkh) 1998;78: 321-325.
  7. Th. Van J, Heule F et al. Cyclosporine in atopic dermatitis. Br J Dermatol. 1994; 130:634-640.
  8. Haw S, Shin MK et al. The efficacy and Safety of Long-term Oral Cyclosporine treatment for patients with Atopic Dermatitis. Ann Dermatol. 2010;22(1):9-15.
  9. Frankel HC, Frangos JE et al. Tapering cyclosporine after long term treatment for atopic dermatitis. J of Eur Acad Dermatol and Venereol. 2011. Jun 4.
  10. Ohtsuka Tsutomu. Response to oral cyclosporine therapy and high sensitivity- CRP level in chronic idiopathic urticaria. Int J Dermatol 2010;49:579-584.
  11. Kessel A. Toubi E. Cyclosporine-A in severe chronic urticaria: the option for long-term therapy. Allergy 2010;65:1478-1482.
  12. Hye YJ, Hei SK, et al. Cyclosporine treatment in a patient with concurrrent Autoimmune urticaria and Autoimmune Hepatitis. Ann Dermatol 2009; 21(3):291-293.
  13. Bertha-Jones J, Smith S G et al. Nodular prurigo responds to cyclosporine. Br J Dermatol 1995;132:795-799.
  14. Wallengren J. Prurigo: diagnosis and management. Am J Clin Dermatol 2004;5 (2):85-95.
  15. Lee. M, Shumack S. Prurigo Nodularis: A review. Australasian Journal of Dermatol 2005; 46:211-220.
  16. Elgart G, Stover P, Larson K, Sutter C,et al. Treatment of pyoderma gangrenosum with cyclosporine: results in seven patients. J Am Acad Dermatol. 1991;24(1):83-6.
  17. Hasselmann DO, Bens G, Tilgen W, Reichrath J. Pyoderma gangrenosum: clinical presentation and outcome in 18 cases and review of the literature. J Dtsch Dermatol Ges 2007;5:560-4
  18. Reich A, Maj J, Cislo M, Szepietowski JC. Periungual lesions in pyoderma gangrenosum. Clin Exp Dermatol 2009;34(5):e81-4.
  19. Reichrath J, Bens G, Bonowitz A, Tilgen W, Treatment recommendations for pyoderma gangrenosum: an evidence based review of the literature based on more than 350 patients. J Am Acad Dermatol 2005;53:273-83.
  20. Soria C, Allegue F, Martin M, Ledo A. Treatment of pyoderma gangrenosum with cyclosporine A. Clinical and experimental Dermatology. 1991 Sep;16(5):392-394.
  21. Turner RB, Emer JJ, Weill M, et al. Rapid resolution of pyoderma gangrenosum after treatment with intravenous cyclosporine. J Am Acad Dermatol. 2010;63(3):e72-4
  22. Friedman S, Marion JF, Scherl E, Rubin PH, Present DH. Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease. Inflamm Bowel Dis 2001;7:1-7
  23. Azizan NZ, Gangaram HB, Hussein SH. A novel therapy for the treatment of pyoderma gangrenosum. Med J Malaysia 2008 Mar;63(1):51-4
  24. Wenzel J, Gerdsen R, Phillipp-Dormston W, et al.Topical treatment of pyoderma gangrenosum. Dermatology 2002;205(3):221-3
  25. Feliciani C, Tulli A. Topical cyclosporine in the treatment of dermatology diseases. Int J Immunopathol Pharmacol. 2002;15(2):89-93
  26. Cohen PR. Neutrophilic Dermatoses : a review of the current treatment options. Am J Clin Dermatol 2009;10 (5):301-12.
  27. Wilson DM, John GR, Callen JP. Peripheral ulcerative keratitis, an extracutaneous neutrophilic disorder: report of a patient with rheumathoid arthritis, pustular vasculitis, pyoderma gangrenosusm and Sweet's syndrome with an excellent response to cyclosporine treatment. J Am Acad Dermatol. 1999;40:331-4
  28. Von Den Driesch P. Sweet's syndrome (acute febrile neutrophilic dermatosis) J Am Acad Dermatol 1994;314:535-56.
  29. Von Den Driesch P. Sweet's syndrome-Therapy with cyclosporin. Clin Experimental Dermatol 1994; 19(3):274-7
  30. Bourke JF, Bertha-Jones J, Graham-Brown RA. Sweet's syndrome responding to Cyclosporin. Br J Dermatol. 1992; 127(1):36-8
  31. Fabbri P, Cardinali C, Giomi B, Caproni M. Cutaneous lupus erythematosus: diagnosis and management. Am J Clin Dermatol. 2003;4:449-65.
  32. Panjwani S. Early diagnosis and treatment of discoid lupus erythematosus. J Am Board Fam Med. 2009;22:206-13.
  33. Rothe MJ, Kerdel FA. Treatment of cutaneous lupus erythematosus. Lupus. 1992;1:351-6.
  34. Ogawa H, Kameda H, Amano K, Takeuchi T. Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice. Lupus. 2010;19:162-9.
  35. Klein A, Vogt T, Wenzel SM, Fleck M, Landthaler M. Cyclosporin combined with methotrexate in two patients with recalcitrant subacute cutaneous lupus erythematosus. Australas J Dermatol. 2011;52:43-7
  36. Grabbe S, Kolde G. Coexisting lichen planus and subacute cutaneous lupus erythematosus. Clin Exp Dermatol. 1995;20:249-54.
  37. Kontochristopoulos GJ, Giannadaki M, Doulaveri G, Christofidou E, Zakopoulou N. Psoriasis coexisting with subacute cutaneous lupus erythematosus. J Eur Acad Dermatol Venereol. 2004;18:385-6.
  38. Gruson LM, Cohen DE. Dermatomyositis. Dermatol Online J. 2004;10:7.
  39. Rosa Neto NS, Goldenstein-Schainberg C. Juvenile dermatomyositis: review and update of the pathogenesis and treatment Rev Bras Reumatol. 2010;50(3):299-312.
  40. Arnson Y, Dovrish Z, Hadari R, Amital H. Amyopathic dermatomyositis--an uncommon presentation of dermatomyositis. Isr Med Assoc J. 2007;9:492-3.
  41. Ytterberg SR. Treatment of refractory polymyositis and dermatomyositis. Curr Rheumatol Rep. 2006;8:167-73.
  42. Amor KT, Ryan C, Menter A. The use of cyclosporine in dermatology: part I J Am Acad Dermatol. 2010;63:925-46.
  43. Iorizzo LJ 3rd, Jorizzo JL. The treatment and prognosis of dermatomyositis: an updated review. J Am Acad Dermatol. 2008;59:99-112.
  44. Vencovský J, Jarosová K, Machácek S, Studýnková J, Kafková J, Bartunková J, Nemcová D, Charvát F. Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis. Scand J Rheumatol. 2000;29:95-102.
  45. Miyake S, Ohtani Y, Sawada M, Inase N, Miyazaki Y, Takano S, Miyasaka N, Yoshizawa Y. Usefulness of cyclosporine A on rapidly progressive interstitial pneumonia in dermatomyositis. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19:128-33.
  46. Mii S, Niiyama S, Kusunoki M, Arai S, Katsuoka K. Cyclosporine A as treatment of esophageal involvement in dermatomyositis Rheumatol Int. 2006;27:183-5.
  47. Shimojima Y, Ishii W, Kato T, Hoshi K, Matsuda M, Hashimoto T, Tanaka Y, Ikeda S. Intractable skin necrosis and interstitial pneumonia in amyopathic dermatomyositis, successfully treated with cyclosporin A. Intern Med. 2003;42:1253-8.
  48. Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: part II. Treatment. J Am Acad Dermatol. 2010;62:191-202.
  49. Ito T, Aoshima M, Ito N, Uchiyama I, Sakamoto K, Kawamura T, Yagi H, Hashizume H, Takigawa M. Combination therapy with oral PUVA and corticosteroid for recalcitrant alopecia areata. Arch Dermatol Res. 2009;301:373-80
  50. Shaheedi-Dadras M, Karami A, Mollaei F, Moravvej H, Malekzad F. The effect of methylprednisolone pulse-therapy plus oral cyclosporine in the treatment of alopecia totalis and universalis. Arch Iran Med. 2008;11:90-3. Erratum in: Arch Iran Med. 2008 Mar;11(2):241.
  51. Kim BJ, Min SU, Park KY, Choi JW, Park SW, Youn SW, Park KC, Huh CH. Combination therapy of cyclosporine and methylprednisolone on severe alopecia areata. J Dermatolog Treat. 2008;19:216-20.
  52. Alpsoy E, Akman A. Behçet's disease: an algorithmic approach to its treatment. Arch Dermatol Res. 2009;301:693-702.
  53. Mendes D, Correia M, Barbedo M, Vaio T, Mota M, Gonçalves O, Valente J.Behçet's disease--a contemporary review. J Autoimmun. 200;32:178-88.
  54. Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH, Kötter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S, Yazici H; EULAR Expert Committee. EULAR recommendations for the management of Behçet disease. Ann Rheum Dis. 2008;67:1656-62.
  55. Lin P, Liang G. Behçet disease: recommendation for clinical management of mucocutaneous lesions. J Clin Rheumatol. 2006 ;12:282-6.
  56. Evereklioglu C. Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol. 2005;50:297-350.
  57. Spadino S, Altomare A, Cainelli C, Franchi C, Frigerio E, Garutti C, Taglioni M, Altomare GF. Disseminated granuloma annulare: efficacy of cyclosporine therapy. Int J Immunopathol Pharmacol. 2006;19:433-8.
  58. Bischoff L, Derk CT. Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature. Int J Dermatol. 2008;47:29-35.
  59. Antic M, Lautenschlager S, Itin PH. Eosinophilic fasciitis 30 years after -what do we really know? Report of 11 patients and review of the literature. Dermatology. 2006;213(2):93-101.
  60. Valencia IC, Chang A, Kirsner RS, Kerdel FA. Eosinophilic fasciitis responsive to treatment with pulsed steroids and cyclosporine. Int J Dermatol. 1999 May;38:369-72.
  61. Bukiej A, Dropiński J, Dyduch G, Szczeklik A. Eosinophilic fasciitis successfully treated with cyclosporine. Clin Rheumatol. 2005;24:634-6.
  62. Tãmas MM, Baican C, Rednic S. Hyperimmunoglobulin E syndrome (Job's syndrome). Rom J Intern Med. 2008;46:169-71.
Close Menu